Riverain Technologies
Founded Year
2004Stage
Series A | AliveTotal Raised
$15MLast Raised
$15M | 3 yrs agoMissing: Riverain Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Riverain Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Riverain Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Riverain Technologies is included in 5 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
9,442 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
11,891 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,912 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health
13,069 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health IT
10,999 items
This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.
Latest Riverain Technologies News
Nov 15, 2022
Benzinga By Pr Newswire ClearRead CT Is the Only Thoracic Imaging Interpretation Solution with Clear Visual Intelligence Using Unique Suppression Technology MIAMISBURG, Ohio, Nov. 15, 2022 /PRNewswire/ --Riverain Technologies, the pioneer of Clear Visual Intelligence (CVI) for chest imaging interpretation, was selected by the Veterans Health Administration (VHA) to provide its unique imaging interpretation solution, ClearRead CT, to the Veteran Affair's (VA) Lung Precision Oncology Program (LPOP). With ClearRead CT, the VA's LPOP patients' care will now include CVI with vessel suppression for chest imaging interpretation alongside standard CT images for interpretation. Improving diagnostic accuracy and earlier intervention for better patient outcomes, ClearRead CT with CVI has shown a 29% reduction in missed nodules and a 26% reduction in nodule search time. AD Riverain Technologies is the pioneer of Clear Visual Intelligence for chest imaging interpretation. About 8,000 veteransare diagnosed and treated by the VA for lung cancer each year, with an estimated 900,000 veterans at risk for lung cancer due to age, smoking, and environmental exposures during and after military service. LPOP chose ClearRead CT to help improve the lung cancer survival rate for veterans across the U.S., which aligns with Riverain's mission to reduce delayed cardio-thoracic disease diagnoses from the nationwide statistic of 1 in 3 to none in 3.
Riverain Technologies Frequently Asked Questions (FAQ)
When was Riverain Technologies founded?
Riverain Technologies was founded in 2004.
Where is Riverain Technologies's headquarters?
Riverain Technologies's headquarters is located at 3020 South Tech Blvd., Miamisburg.
What is Riverain Technologies's latest funding round?
Riverain Technologies's latest funding round is Series A.
How much did Riverain Technologies raise?
Riverain Technologies raised a total of $15M.
Who are the investors of Riverain Technologies?
Investors of Riverain Technologies include Ping An Ventures and John Rompon.
Who are Riverain Technologies's competitors?
Competitors of Riverain Technologies include Aidence and 1 more.
Compare Riverain Technologies to Competitors
Ultromics provides autonomous echocardiography analysis through AI solutions, empowering physicians to make decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing reports for clinicians without any need for physical software on-site. The company was founded in 2017 and is based in Oxford, U.K.
ZERO& is an American snack beverage and food company.
Carestream is a provider of medical imaging systems, x-ray imaging systems for non-destructive testing, and precision contract coating services for a wide range of industrial, medical, electronic, and other applications. It was founded in 2007 and is based in Rochester, New York.
Optellum develops software for the personalized early diagnosis and treatment of lung cancer. It provides an end-to-end IT platform for personalized early diagnosis and therapy. Its products include clinical decision support software for personalized early diagnosis and treatment of lung cancer, based on Artificial Intelligence (AI) and machine learning. The company was founded in 2016 and is based in Oxford, U.K.
Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.
contextflow develops deep-learning-based tools that aim to improve radiologists’ daily clinical workflows. The company offers a 3D image-based search engine called SEARCH, which provides reference cases based on visual disease pattern detection, statistics, and medical literature necessary for differential diagnosis. The company was founded in 2016 and is based in Vienna, Austria.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.